Cargando…
Nanotherapeutics Plus Immunotherapy in Oncology: Who Brings What to the Table?
While the number of oncology-related nanotherapeutics and immunotherapies is constantly increasing, cancer patients still suffer from a lack of efficacy and treatment resistance. Among the investigated strategies, patient selection and combinations appear to be of great hope. This review will focus...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697974/ https://www.ncbi.nlm.nih.gov/pubmed/36365144 http://dx.doi.org/10.3390/pharmaceutics14112326 |